See all community posts
Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19

Not a big mover but possible upside with news. Yearly chart is in a  nice and steady upward channel.

Posted Sep 16, 20 9:18 AMbyMichaelBMaxey
Categories  Breaking News
Tickers  RVVTF
Views 135 / 0
gatorca68
gatorca68 Sep 16, 20 9:59 AM

I went long here and finally some good news :-)

MichaelBMaxey
MichaelBMaxey Sep 21, 20 6:41 AM

Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100™ and Selection of Commercial Partners

Join now or log in to leave a comment